You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AGS67E

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Lymphoid Malignancy, Refractory Lymphoid Malignancy Trial in Canada, United States (AGS67E)

Completed
  • Relapsed Lymphoid Malignancy
  • Refractory Lymphoid Malignancy
  • AGS67E
  • Duarte, California
  • +4 more
Nov 27, 2020

Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,

Not yet recruiting
  • Metastatic Penile Squamous Cell Carcinoma
  • +3 more
  • Enfortumab Vedotin
  • Phoenix, Arizona
  • +2 more
Oct 23, 2023

Acute Myeloid Leukemia Trial in Canada, United States (AGS67E)

Terminated
  • Acute Myeloid Leukemia
  • AGS67E
  • Duarte, California
  • +3 more
Jul 22, 2019

Renal Pelvis and Ureter Urothelial Carcinoma Trial in Los Angeles (procedure, drug, biological)

Not yet recruiting
  • Renal Pelvis and Ureter Urothelial Carcinoma
  • Biopsy
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 15, 2023

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
  • +3 more
  • Cabozantinib S-malate
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 8, 2022

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting
  • Bladder Squamous Cell Carcinoma
  • +10 more
  • Biospecimen Collection
  • +5 more
  • Atlanta, Georgia
  • +3 more
Feb 20, 2023

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Los Angeles, California
  • +2 more
Jun 28, 2022

Metastatic Renal Cell Carcinoma Trial in Canada, United States (AGS-16C3F, Axitinib)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Tucson, Arizona
  • +25 more
Nov 9, 2021

Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology Trial in

Completed
  • Carcinoma, Renal Cell
  • +3 more
  • Ann Arbor, Michigan
  • +8 more
Dec 16, 2020

Primary Mitochondrial Disease Trial in Germany, Italy (OMT-28)

Recruiting
  • Primary Mitochondrial Disease
  • Bonn, Germany
  • +5 more
Aug 3, 2023

Neuroendocrine Tumors Trial in Montréal (68Ga-DOTATATE PET/CT)

Enrolling by invitation
  • Neuroendocrine Tumors
  • 68Ga-DOTATATE PET/CT
  • Montréal, Quebec, Canada
    Jewish General Hospital
Feb 8, 2021

PTSD Trial in Worldwide (MDMA)

Recruiting
  • PTSD
  • Klecany, Středočeský Kraj, Czechia
  • +8 more
Aug 25, 2022

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • La Jolla, California
  • +159 more
Jan 23, 2023

Heparin-induced Thrombocytopenia Trial in Worldwide (Danaparoid Sodium, Argatroban)

Terminated
  • Heparin-induced Thrombocytopenia
  • Gainesville, Florida
  • +34 more
Dec 6, 2022

Metastatic Urothelial Cancer Trial in Canada, United States (AGS15E)

Completed
  • Metastatic Urothelial Cancer
  • Birmingham, Alabama
  • +10 more
Jun 22, 2020

ADHD Trial in Worldwide (Guanfacine HCl (TAK-503), Atomoxetine HCl, Placebo)

Recruiting
  • Attention Deficit Hyperactivity Disorder
  • Guanfacine hydrochloride (TAK-503)
  • +2 more
  • Dothan, Alabama
  • +42 more
Aug 19, 2022

Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Brasschaat, Belgium
  • +53 more
Nov 29, 2022

Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in Worldwide (HZN-825 BID, Placebo, HZN-825 QD)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Sclerosis, Systemic
  • HZN-825 BID
  • +2 more
  • Phoenix, Arizona
  • +48 more
Jun 21, 2022

Systemic Lupus Erythematosus Trial in Worldwide (LY3361237, Placebo)

Recruiting
  • Systemic Lupus Erythematosus
  • Mesa, Arizona
  • +49 more
Jan 17, 2023

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
  • Birmingham, Alabama
  • +91 more
Jan 26, 2023

Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine

Recruiting
  • Aicardi-Goutières Syndrome
  • Abacavir (ABC)
  • +2 more
  • Edinburgh, United Kingdom
    Yanick Crow
Aug 26, 2022

Polypharmacy, Multimorbidity, Aged Trial (Multidisciplinary Approach Group)

Not yet recruiting
  • Polypharmacy
  • +2 more
  • Multidisciplinary Approach Group
  • (no location specified)
Mar 3, 2021

Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO

Recruiting
  • COVID
  • +6 more
    • Innsbruck, Austria
    • +96 more
    Sep 3, 2021

    Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

    Completed
    • Hyperkalemia
    • Alexander City, Alabama
    • +414 more
    Jan 11, 2022

    Schizophrenia Trial in Worldwide (Luvadaxistat, Placebo)

    Completed
    • Schizophrenia
    • Garden Grove, California
    • +53 more
    Dec 7, 2021